Shares of Cardinal Health, Inc. (NYSE:CAH – Get Rating) have been assigned an average rating of "Moderate Buy" from the twelve brokerages that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $70.20.
Several research analysts recently weighed in on the company. StockNews.com upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Friday, August 12th. UBS Group boosted their price objective on Cardinal Health from $61.00 to $78.00 and gave the company a "buy" rating in a research report on Monday, August 29th. Robert W. Baird boosted their price objective on Cardinal Health from $57.00 to $73.00 and gave the company a "neutral" rating in a research report on Friday, August 12th. Barclays boosted their price objective on Cardinal Health to $67.00 in a research report on Monday, August 15th. Finally, Evercore ISI boosted their price target on Cardinal Health to $75.00 in a research report on Monday, August 15th.
Get Cardinal Health alerts:Cardinal Health Trading Down 1.8 %
Cardinal Health stock opened at $66.05 on Friday. The company has a quick ratio of 0.57, a current ratio of 1.08 and a debt-to-equity ratio of 5.33. Cardinal Health has a 52 week low of $45.85 and a 52 week high of $72.28. The company has a market capitalization of $18.00 billion, a price-to-earnings ratio of 9.92, a price-to-earnings-growth ratio of 1.50 and a beta of 0.77. The stock has a 50-day moving average price of $65.20 and a 200 day moving average price of $59.41.
Cardinal Health (NYSE:CAH – Get Rating) last released its earnings results on Thursday, August 11th. The company reported $1.05 EPS for the quarter, missing analysts' consensus estimates of $1.17 by ($0.12). The firm had revenue of $47.10 billion for the quarter, compared to analyst estimates of $44.82 billion. Cardinal Health had a positive return on equity of 568.57% and a negative net margin of 0.51%. The company's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period last year, the firm earned $0.77 EPS. Sell-side analysts anticipate that Cardinal Health will post 5.27 EPS for the current year.Cardinal Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Saturday, October 15th. Investors of record on Monday, October 3rd will be paid a dividend of $0.4957 per share. This represents a $1.98 annualized dividend and a yield of 3.00%. The ex-dividend date is Friday, September 30th. Cardinal Health's payout ratio is 29.73%.
Institutional Investors Weigh In On Cardinal Health
Large investors have recently bought and sold shares of the stock. Manchester Capital Management LLC boosted its position in shares of Cardinal Health by 60.4% in the 1st quarter. Manchester Capital Management LLC now owns 494 shares of the company's stock valued at $28,000 after purchasing an additional 186 shares during the period. LS Investment Advisors LLC acquired a new stake in Cardinal Health during the 2nd quarter worth approximately $27,000. Landmark Wealth Management LLC acquired a new stake in Cardinal Health during the 1st quarter worth approximately $62,000. CX Institutional acquired a new stake in Cardinal Health during the 2nd quarter worth approximately $33,000. Finally, Cornerstone Advisory LLC acquired a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $35,000. Hedge funds and other institutional investors own 85.07% of the company's stock.
Cardinal Health Company Profile
(Get Rating)
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Get a free copy of the StockNews.com research report on Cardinal Health (CAH)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 2 Semiconductor Stocks To Watch For Reversals
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.